Rich nations are hoarding potential COVID-19 vaccine doses: Oxfam

Rich nations are hoarding potential COVID-19 vaccine doses: Oxfam
CDC Director Dr. Robert Redfield visited the NIH on June 12, 2018. In this image Dr. Redfield visits the Vaccine Research Center and learns about universal flu vaccine development. Dr. Anthony Fauci (r), Director of NIAID, accompanied the visit. Credit: National Institutes of Health

Oxfam on Thursday reiterated its call for a "people's vaccine" as the anti-poverty group released a new analysis showing that a handful of rich nations representing just 13 percent of the world's population have snatched up over half of the promised Covid-19 vaccine doses.

"Access to a life-saving vaccine shouldn't depend on where you live or how much money you have," Robert Silverman, advocacy manager in Oxfam America's Private Sector department, said in a statement.

"The development and approval of a safe and effective vaccine is crucial," he said, "but equally important is making sure the vaccines are available and affordable to everyone."

In its findings, based on data from science analytics company Airfinity, Oxfam notes that nine vaccines are currently going through phase 3 clinical trials. Supply deals are known for five of those potential vaccines, and are being developed pharmaceutical giants by AstraZeneca, Gamaleya/Sputnik, Moderna, Pfizer and Sinovac.

The analysis comes amid swelling calls from global leaders, health experts, and groups including Oxfam for a so-called people's vaccine for the novel coronavirus. That effort would put the needs of public health above corporate profits and reject nationalist approaches towards vaccine acquisition.

According to Oxfam, out of supply deals inked for 5.3 billion doses, 51 percent—2.728 billion—were bought by wealthy nations including the U.K., U.S., Australia, Hong Kong and Macau, Japan, Switzerland, and Israel, and well as the European Union.

The group further warns that even if the five potential vaccines turn out to be sufficiently safe and effective—an unlikely scenario—the coming year would still be marked by the public health crisis because 61% of the world's population would likely not have a vaccine until at least 2022.

As Silverman noted in his statement, "Covid-19 anywhere is Covid-19 everywhere."

That simply underscores the need for a people's vaccine, says Chema Vera, interim executive director of Oxfam International.

"Governments will prolong this crisis in all of its human tragedy and economic damage if they allow pharmaceutical companies to protect their monopolies and profits," said Vera.

"No single corporation will ever be able to meet the world's need for a ovid-19 vaccine," he said, urging companies to "share their knowledge free of patents and to get behind a quantum leap in production to keep everyone safe."

"We need a people's vaccine, not a profit vaccine," Vera said.

Enjoy this piece?

… then let us make a small request. AlterNet’s journalists work tirelessly to counter the traditional corporate media narrative. We’re here seven days a week, 365 days a year. And we’re proud to say that we’ve been bringing you the real, unfiltered news for 20 years—longer than any other progressive news site on the Internet.

It’s through the generosity of our supporters that we’re able to share with you all the underreported news you need to know. Independent journalism is increasingly imperiled; ads alone can’t pay our bills. AlterNet counts on readers like you to support our coverage. Did you enjoy content from David Cay Johnston, Common Dreams, Raw Story and Robert Reich? Opinion from Salon and Jim Hightower? Analysis by The Conversation? Then join the hundreds of readers who have supported AlterNet this year.

Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure AlterNet remains independent long into the future. Support progressive journalism with a one-time contribution to AlterNet, or click here to become a subscriber. Thank you. Click here to donate by check.